【摘要】 目的:研究布地奈德、异丙托溴铵联合雾化吸入加用口服急支糖浆对小儿支原体肺炎的疗效。方法:将2011年5月-2012年5月在我院诊断为肺炎支原体肺炎,年龄3～14岁的69例住院患儿,随机分为对照组35例与试验组34例。在给予抗感染的基础上试验组应用布地奈德、异丙托溴铵氧气驱动雾化吸入加用口服急支糖浆,观察比较两组疗效。结果:试验组患儿咳嗽消失时间、肺部罗音消失时间及住院时间均比对照组有极显著缩短(P<0.01),试验组总有效率比对照组高(P<0.01)。结论:布地奈德、异丙托溴铵氧气驱动雾化吸入加用口服急支糖浆可以作为治疗小儿支原体肺炎的辅助治疗方式。更多还原

【Abstract】 Objective:To study the budesonide,ipratropium bromide Stock aerosol inhalation plus oral acute bronchitis syrup efficacy of mycoplasma pneumonia in children.Method:from May 2011 to May 2012 in our hospital diagnosed with pneumonia,mycoplasma pneumonia,aged 3 to 14 years old,69 cases of hospitalized children,35 cases were randomly divided into a control group and a test group of 34 patients.Test group application budesonide,ipratropium bromide atomizing inhalation plus oral acute bronchitis syrup,observation and comparison of the two groups on the basis of given antibiotics.Experimental group,children with cough disappeared time,of pulmonary rales disappear and hospitalization time there was significantly shorter(P<0.01) than the control group,the total effective rate in the test group than the control group(P<0.01).Conclusion:Budesonide,ipratropium bromide oxygen drive to the aerosol inhalation plus oral acute bronchitis syrup can be used as auxiliary treatment of mycoplasma pneumonia treatment.更多还原